Dysglycemia and Cardiovascular Risk in the General Population

被引：20

作者：

Gerstein, Hertzel C. ^{[1
,2
,3
]}

机构：

[1] McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada

[2] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8N 3Z5, Canada

[3] Hamilton Hlth Sci, Hamilton, ON, Canada

来源：

CIRCULATION | 2009年 / 119卷 / 06期

关键词：

Editorials; epidemiology; glucose; myocardial infarction; risk factors; stroke; ACUTE MYOCARDIAL-INFARCTION; BLOOD-GLUCOSE; HEART-DISEASE; HEMOGLOBIN A(1C); MORTALITY; HOSPITALIZATION; COMPLICATIONS; ASSOCIATION; FAILURE; STROKE;

D O I：

10.1161/CIRCULATIONAHA.108.834408

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：773 / 775

页数：3

共 25 条

[1]

Brunner EJ, 2006, DIABETES CARE, V29, P26

[2] Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment [J].

Danaei, Goodarz ;

Lawes, Carlene M. M. ;

Hoorn, Stephen Vander ;

Murray, Christopher J. L. ;

Ezzati, Majid .

LANCET, 2006, 368 (9548) :1651-1659

[3] Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes [J].

Duckworth, William ;

Abraira, Carlos ;

Moritz, Thomas ;

Reda, Domenic ;

Emanuele, Nicholas ;

Reaven, Peter D. ;

Zieve, Franklin J. ;

Marks, Jennifer ;

Davis, Stephen N. ;

Hayward, Rodney ;

Warren, Stuart R. ;

Goldman, Steven ;

McCarren, Madeline ;

Vitek, Mary Ellen ;

Henderson, William G. ;

Huang, Grant D. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (02) :129-U62

[4]

Gavin JR, 1997, DIABETES CARE, V20, P1183

[5] The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis [J].

Gerstein, HC ;

Pogue, J ;

Mann, JFE ;

Lonn, E ;

Dagenais, GR ;

McQueen, M ;

Yusuf, S .

DIABETOLOGIA, 2005, 48 (09) :1749-1755

[6] Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: The ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention) [J].

Gerstein, Hertzei C. .

AMERICAN HEART JOURNAL, 2008, 155 (01) :26-32

[7] The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure -: An analysis of the Candesartan in Heart failure:: Assessment of Reduction in Mortality and Morbidity (CHARM) program [J].

Gerstein, Hertzel C. ;

Swedberg, Karl ;

Carlsson, Jonas ;

McMurray, John J. V. ;

Michelson, Eric L. ;

Olofsson, Bertil ;

Pfeffer, Marc A. ;

Yusuf, Salim .

ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (15) :1699-1704

[8]

Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743

[9] Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study [J].

Goyal, Abhinav ;

Mahaffey, Kenneth W. ;

Garg, Jyotsna ;

Nicolau, Jose C. ;

Hochman, Judith S. ;

Weaver, W. Douglas ;

Theroux, Pierre ;

Oliveira, Gustavo B. F. ;

Todaro, Thomas G. ;

Mojcik, Christopher F. ;

Armstrong, Paul W. ;

Granger, Christopher B. .

EUROPEAN HEART JOURNAL, 2006, 27 (11) :1289-1297

[10] Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk [J].

Held, C. ;

Gerstein, H. C. ;

Yusuf, S. ;

Zhao, F. ;

Hilbrich, L. ;

Anderson, C. ;

Sleight, P. ;

Teo, K. .

CIRCULATION, 2007, 115 (11) :1371-1375

← 1 2 3 →